Will MacInnis

Will MacInnis is a seasoned professional in the finance and healthcare sectors, currently serving as Co-Founder and Co-CEO at Cliff Ridge Specialty Partners since 2024 and as Managing Partner at 49 Mile Ventures since May 2023. Previously, Will held the position of Executive Vice President of Finance at Vial from August 2021 to April 2023 and worked as a Private Equity Associate at TPG in the Healthcare Group from August 2018 to July 2021. Additional board observer roles include significant companies such as Kadiant, Kindred at Home, and Kindred Healthcare, all of which were acquired during Will's tenure. Will also served as a board observer and Interim CFO at Asklepios BioPharmaceutical, Inc. prior to its acquisition by Bayer. Will's professional journey began at Credit Suisse as an Investment Banking Analyst in the Healthcare Group from July 2016 to June 2018. Will holds an Honors Business Administration degree from Ivey Business School at Western University.